LAMEA Nephrostomy Devices Market (2019-2025)
The Latin America, Middle East and Africa Nephrostomy Devices Market would witness market growth of 9.06% CAGR during the forecast period (2019-2025). The incidence of ovarian, kidney, bladder and prostate cancer underscores the advantages of nephrostomy devices while lessening the composition of the therapy cost in several nations, governments and private organizations. Likewise, the focus is on initiatives that spread awareness about nephrostomy devices. The growth of the market is anticipated to give opportunities to such projects over the years to come.
PCNL is the most preferred minimally invasive technique. Over the years, advances in PCNL have been made in technology and instruments to reduce morbidity and improve efficiency. In the past, major morbidity has been correlated with urological complications following renal transplantation. These cases can now be managed with minimally invasive techniques by the development and application of endourological procedures. Tubeless mini-percutaneous nephrolithotomy (MILT) is one of the most effective ways to treat larger stones in the kidney.
Based on Product, the market is segmented into Guidewires, Sheath Dilators, Nephrostomy Catheters, Drainage Tubes and Other Nephrostomy Devices. Based on End Use, the market is segmented into Hospital, Ambulatory Surgical Centers (ASCs) and Emergency Clinics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.
Scope of the Study
Market Segmentation:
By Product
PCNL is the most preferred minimally invasive technique. Over the years, advances in PCNL have been made in technology and instruments to reduce morbidity and improve efficiency. In the past, major morbidity has been correlated with urological complications following renal transplantation. These cases can now be managed with minimally invasive techniques by the development and application of endourological procedures. Tubeless mini-percutaneous nephrolithotomy (MILT) is one of the most effective ways to treat larger stones in the kidney.
Based on Product, the market is segmented into Guidewires, Sheath Dilators, Nephrostomy Catheters, Drainage Tubes and Other Nephrostomy Devices. Based on End Use, the market is segmented into Hospital, Ambulatory Surgical Centers (ASCs) and Emergency Clinics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.
Scope of the Study
Market Segmentation:
By Product
- Guidewires
- Sheath Dilators
- Nephrostomy Catheters
- Drainage Tubes
- Other Nephrostomy Devices
- Hospital
- Ambulatory Surgical Centers (ASCs)
- Emergency Clinics
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Boston Scientific Corporation
- Teleflex, Inc.
- Cook Medical, Inc. (Cook Group)
- Coloplast Group
- Olympus Corporation
- Argon Medical Devices, Inc.
- UreSil LLC
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Nephrostomy Devices Market, by Product
1.4.2 LAMEA Nephrostomy Devices Market, by End Use
1.4.3 LAMEA Nephrostomy Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition: 2019-May-2015-Mar) Leading Players
CHAPTER 4. LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT
4.1 LAMEA Guidewires Market by Country
4.2 LAMEA Sheath Dilators Market by Country
4.3 LAMEA Nephrostomy Catheters Market by Country
4.4 LAMEA Drainage Tubes Market by Country
4.5 LAMEA Other Nephrostomy Devices Market by Country
CHAPTER 5. LAMEA NEPHROSTOMY DEVICES MARKET BY END USE
5.1 LAMEA Hospital Market by Country
5.2 LAMEA Ambulatory Surgical Centers (ASCs) Market by Country
5.3 LAMEA Emergency Clinics Market by Country
CHAPTER 6. LAMEA NEPHROSTOMY DEVICES MARKET BY COUNTRY
6.1 Brazil Nephrostomy Devices Market
6.1.1 Brazil Nephrostomy Devices Market by Product
6.1.2 Brazil Nephrostomy Devices Market by End Use
6.2 Argentina Nephrostomy Devices Market
6.2.1 Argentina Nephrostomy Devices Market by Product
6.2.2 Argentina Nephrostomy Devices Market by End Use
6.3 UAE Nephrostomy Devices Market
6.3.1 UAE Nephrostomy Devices Market by Product
6.3.2 UAE Nephrostomy Devices Market by End Use
6.4 Saudi Arabia Nephrostomy Devices Market
6.4.1 Saudi Arabia Nephrostomy Devices Market by Product
6.4.2 Saudi Arabia Nephrostomy Devices Market by End Use
6.5 South Africa Nephrostomy Devices Market
6.5.1 South Africa Nephrostomy Devices Market by Product
6.5.2 South Africa Nephrostomy Devices Market by End Use
6.6 Nigeria Nephrostomy Devices Market
6.6.1 Nigeria Nephrostomy Devices Market by Product
6.6.2 Nigeria Nephrostomy Devices Market by End Use
6.7 Rest of LAMEA Nephrostomy Devices Market
6.7.1 Rest of LAMEA Nephrostomy Devices Market by Product
6.7.2 Rest of LAMEA Nephrostomy Devices Market by End Use
CHAPTER 7. COMPANY PROFILES
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Collaborations, partnerships and agreements:
7.1.5.2 Acquisition and mergers:
7.1.5.3 Product launches:
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Expansions:
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Collaborations, partnerships and agreements:
7.3.2.2 Product launches:
7.3.2.3 Expansions:
7.4 Coloplast Group
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.5 Olympus Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Product launches:
7.5.5.3 Acquisition and mergers:
7.6 Argon Medical Devices, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisition and mergers:
7.7 UreSil LLC
7.7.1 Company Overview
7.8 B. Braun Melsungen AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Acquisition and mergers:
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Collaborations, partnerships and agreements:
7.9.4.2 Product launches:
7.1 Becton, Dickinson and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Nephrostomy Devices Market, by Product
1.4.2 LAMEA Nephrostomy Devices Market, by End Use
1.4.3 LAMEA Nephrostomy Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition: 2019-May-2015-Mar) Leading Players
CHAPTER 4. LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT
4.1 LAMEA Guidewires Market by Country
4.2 LAMEA Sheath Dilators Market by Country
4.3 LAMEA Nephrostomy Catheters Market by Country
4.4 LAMEA Drainage Tubes Market by Country
4.5 LAMEA Other Nephrostomy Devices Market by Country
CHAPTER 5. LAMEA NEPHROSTOMY DEVICES MARKET BY END USE
5.1 LAMEA Hospital Market by Country
5.2 LAMEA Ambulatory Surgical Centers (ASCs) Market by Country
5.3 LAMEA Emergency Clinics Market by Country
CHAPTER 6. LAMEA NEPHROSTOMY DEVICES MARKET BY COUNTRY
6.1 Brazil Nephrostomy Devices Market
6.1.1 Brazil Nephrostomy Devices Market by Product
6.1.2 Brazil Nephrostomy Devices Market by End Use
6.2 Argentina Nephrostomy Devices Market
6.2.1 Argentina Nephrostomy Devices Market by Product
6.2.2 Argentina Nephrostomy Devices Market by End Use
6.3 UAE Nephrostomy Devices Market
6.3.1 UAE Nephrostomy Devices Market by Product
6.3.2 UAE Nephrostomy Devices Market by End Use
6.4 Saudi Arabia Nephrostomy Devices Market
6.4.1 Saudi Arabia Nephrostomy Devices Market by Product
6.4.2 Saudi Arabia Nephrostomy Devices Market by End Use
6.5 South Africa Nephrostomy Devices Market
6.5.1 South Africa Nephrostomy Devices Market by Product
6.5.2 South Africa Nephrostomy Devices Market by End Use
6.6 Nigeria Nephrostomy Devices Market
6.6.1 Nigeria Nephrostomy Devices Market by Product
6.6.2 Nigeria Nephrostomy Devices Market by End Use
6.7 Rest of LAMEA Nephrostomy Devices Market
6.7.1 Rest of LAMEA Nephrostomy Devices Market by Product
6.7.2 Rest of LAMEA Nephrostomy Devices Market by End Use
CHAPTER 7. COMPANY PROFILES
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Collaborations, partnerships and agreements:
7.1.5.2 Acquisition and mergers:
7.1.5.3 Product launches:
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Expansions:
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Collaborations, partnerships and agreements:
7.3.2.2 Product launches:
7.3.2.3 Expansions:
7.4 Coloplast Group
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.5 Olympus Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Product launches:
7.5.5.3 Acquisition and mergers:
7.6 Argon Medical Devices, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisition and mergers:
7.7 UreSil LLC
7.7.1 Company Overview
7.8 B. Braun Melsungen AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Acquisition and mergers:
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Collaborations, partnerships and agreements:
7.9.4.2 Product launches:
7.1 Becton, Dickinson and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
LIST OF TABLES
TABLE 1 LAMEA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEPHROSTOMY DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND EXPANSIONS– NEPHROSTOMY DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEPHROSTOMY DEVICES MARKET
TABLE 6 LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 7 LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 8 LAMEA GUIDEWIRES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 LAMEA GUIDEWIRES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 LAMEA SHEATH DILATORS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 LAMEA SHEATH DILATORS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 LAMEA NEPHROSTOMY CATHETERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 LAMEA NEPHROSTOMY CATHETERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 LAMEA DRAINAGE TUBES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 15 LAMEA DRAINAGE TUBES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 16 LAMEA OTHER NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 LAMEA OTHER NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 LAMEA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 19 LAMEA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 20 LAMEA HOSPITAL MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 LAMEA HOSPITAL MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 LAMEA AMBULATORY SURGICAL CENTERS (ASCS) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 LAMEA AMBULATORY SURGICAL CENTERS (ASCS) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 LAMEA EMERGENCY CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 LAMEA EMERGENCY CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 LAMEA NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 27 LAMEA NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 28 BRAZIL NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 29 BRAZIL NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 30 BRAZIL NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 31 BRAZIL NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 32 BRAZIL NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 33 BRAZIL NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 34 ARGENTINA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 35 ARGENTINA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 36 ARGENTINA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 37 ARGENTINA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 38 ARGENTINA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 39 ARGENTINA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 40 UAE NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 41 UAE NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 42 UAE NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 43 UAE NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 44 UAE NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 45 UAE NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 46 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 47 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 48 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 49 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 50 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 51 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 52 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 53 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 54 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 55 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 56 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 57 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 58 NIGERIA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 59 NIGERIA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 60 NIGERIA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 61 NIGERIA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 62 NIGERIA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 63 NIGERIA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 64 REST OF LAMEA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 65 REST OF LAMEA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 66 REST OF LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 67 REST OF LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 68 REST OF LAMEA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 69 REST OF LAMEA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 70 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 71 KEY INFORMATION – TELEFLEX, INC.
TABLE 72 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 73 KEY INFORMATION – COLOPLAST GROUP
TABLE 74 KEY INFORMATION – OLYMPUS CORPORATION
TABLE 75 KEY INFORMATION – ARGON MEDICAL DEVICES, INC.
TABLE 76 KEY INFORMATION – URESIL LLC
TABLE 77 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 78 KEY INFORMATION – CARDINAL HEALTH, INC.
TABLE 79 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 1 LAMEA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEPHROSTOMY DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND EXPANSIONS– NEPHROSTOMY DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEPHROSTOMY DEVICES MARKET
TABLE 6 LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 7 LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 8 LAMEA GUIDEWIRES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 LAMEA GUIDEWIRES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 LAMEA SHEATH DILATORS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 LAMEA SHEATH DILATORS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 LAMEA NEPHROSTOMY CATHETERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 LAMEA NEPHROSTOMY CATHETERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 LAMEA DRAINAGE TUBES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 15 LAMEA DRAINAGE TUBES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 16 LAMEA OTHER NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 LAMEA OTHER NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 LAMEA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 19 LAMEA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 20 LAMEA HOSPITAL MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 LAMEA HOSPITAL MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 LAMEA AMBULATORY SURGICAL CENTERS (ASCS) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 LAMEA AMBULATORY SURGICAL CENTERS (ASCS) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 LAMEA EMERGENCY CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 LAMEA EMERGENCY CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 LAMEA NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 27 LAMEA NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 28 BRAZIL NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 29 BRAZIL NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 30 BRAZIL NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 31 BRAZIL NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 32 BRAZIL NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 33 BRAZIL NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 34 ARGENTINA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 35 ARGENTINA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 36 ARGENTINA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 37 ARGENTINA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 38 ARGENTINA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 39 ARGENTINA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 40 UAE NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 41 UAE NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 42 UAE NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 43 UAE NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 44 UAE NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 45 UAE NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 46 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 47 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 48 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 49 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 50 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 51 SAUDI ARABIA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 52 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 53 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 54 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 55 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 56 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 57 SOUTH AFRICA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 58 NIGERIA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 59 NIGERIA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 60 NIGERIA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 61 NIGERIA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 62 NIGERIA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 63 NIGERIA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 64 REST OF LAMEA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 65 REST OF LAMEA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 66 REST OF LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 67 REST OF LAMEA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 68 REST OF LAMEA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 69 REST OF LAMEA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 70 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 71 KEY INFORMATION – TELEFLEX, INC.
TABLE 72 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 73 KEY INFORMATION – COLOPLAST GROUP
TABLE 74 KEY INFORMATION – OLYMPUS CORPORATION
TABLE 75 KEY INFORMATION – ARGON MEDICAL DEVICES, INC.
TABLE 76 KEY INFORMATION – URESIL LLC
TABLE 77 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 78 KEY INFORMATION – CARDINAL HEALTH, INC.
TABLE 79 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION: 2019-MAY-2015-MAR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: TELEFLEX, INC.
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: COOK MEDICAL, INC. (COOK GROUP)
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: OLYMPUS CORPORATION
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION: 2019-MAY-2015-MAR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: TELEFLEX, INC.
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: COOK MEDICAL, INC. (COOK GROUP)
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: OLYMPUS CORPORATION
